Fresenius Kabi Issues Critical Software Update for Ivenix Infusion Pumps
FDA identifies Class I recall as most serious type due to software anomalies that may cause unexpected shutdowns and interface freezing.
FDA identifies Class I recall as most serious type due to software anomalies that may cause unexpected shutdowns and interface freezing.
The mobile C-arm system features AI-powered imaging tools and cable-free design for interventional procedures.
More than 100 healthcare organizations are calling on HHS to withdraw the proposed HIPAA Security Rule update and pursue a collaborative approach to cybersecurity standards.
Read MoreThe system is designed to give surgeons a clear, real-time view of critical anatomy and planned trajectories.Â
Read MoreNew guidance permits the use of de-identified data without requiring individual patient information in marketing submissions.Â
Read More43% of hospital security leaders name IoMT visibility as their top cybersecurity challenge, while internal process issues create the biggest obstacle to effective risk management.
Read MoreUS PIRG is surveying HTM professionals to document how repair restrictions affect patient care, downtime, and costs.
Read MoreAs Accreditation 360 rolls out in January 2026, the Joint Commission explains what’s changing, what isn’t, and how HTM teams can prepare.
Read MoreGE HealthCare is updating use instructions after reports certain systems may not switch to battery mode during AC power loss, potentially disrupting ventilation and agent delivery.
Read MoreNew AI cybersecurity guidance is set to roll out in early 2026, as AI becomes more embedded in healthcare technology.
Read MoreBipartisan provisions that would have expanded military access to repair data and technical information were removed from the final FY26 defense authorization bill.
Read MoreThe pilot will evaluate a new, risk-based enforcement approach that supports digital health devices intended for use in chronic conditions.
Read MoreThe company is pulling the Life2000 system from the market after finding a vulnerability that could allow unauthorized changes to ventilation settings.
Read MoreThe FDA issued a safety alert after users reported nitric oxide dose fluctuations, potentially leading to hypoxemia or increased pulmonary artery pressure.Â
Read More